Jackson Health System projects 47% reduction in carbon emissions from patient monitors with Philips next generation monitoring platform
Bitget and Foresight Ventures Invest $30 Million in TON Blockchain to Accelerate Growing Telegram-based Projects
Acronis Announces First Ever #TeamUp Partnership in Germany with FC Bayern Basketball, Backed by TD SYNNEX
Teva Announces Long Term Efficacy and Safety of Deutetrabenazine in European Patients with Debilitating Movement Disorder Tardive Dyskinesia
Queen Mathilde of Belgium, Prince Harry, Duke of Sussex, Forest Whitaker, UN Agency Heads and other dignitaries join survivors and advocates for ending child violence in New York, during the UN General Assembly
Teva Presents New Phase 3 Efficacy, Safety and Tolerability Data from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable for Adult Patients Diagnosed with Schizophrenia
New Data Provide Treatment Insights into Options for Switching Adult Patients Diagnosed with Schizophrenia to UZEDY® (risperidone) Extended-Release Injectable Suspension from Perseris® (RBP-7000)